STAB logo

Statera Biopharma, Inc. (STAB)

Profile

Full Name

Statera Biopharma, Inc.

Ticker

NASDAQ: STAB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 28, 2021

Indexes

Not included

Website

https://www.staterabiopharma.com

Employees

46

Key Details

Price

$0.00(0.00%)

Market cap

$5466.19(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.49M(+100.00% YoY)

Annual EPS

-$2.90(-74.70% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.00
    STAB price is $0.00

    30-Day Relative Volume

    0.00
    STAB 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    0%
    STAB price has remained unchanged on Sep 16, 2025

    Price YTD change

    0%
    STAB price has remained unchanged since January 1st

    Price 1-year change

    0%
    STAB price has remained unchanged year-on-year

    Price 3-year change

    -99.94%
    STAB price is down -99.94% over the past 3 years

    Price Range

    Price All-time high

    $273.60
    STAB price is currently -100.00% below its historical high of $273.60

    Price 3-year low

    $0.00
    STAB price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5466.19
    STAB market capitalization is $5466.19

    Market cap 3-year change

    -99.94%
    STAB market capitalization is down -99.94% over the past 3 years

    Market cap All-time high

    $138.89M
    STAB market capitalization is currently -100.00% below its historical high of $138.89 million

    Market cap sector rank

    1.09%
    STAB market capitalization is higher than 1.09% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    STAB shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +6.88%
    STAB shares outstanding is up +6.88% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.39
    STAB beta is -0.39

    200-day SMA

    $0.00
    STAB price is currently equal to its 200-day simple moving average

    50-day SMA

    $0.00
    STAB price is currently equal to its 50-day simple moving average

    RSI

    50.00
    STAB 14-day relative strength index is 50.00

    Volume

    0.00
    STAB 30-day relative volume is 0.00

    ATR

    $0.00
    STAB average true range is $0.00

    10-day Historical Volatility

    251.00%
    STAB 10-day historical volatility is 251.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.49M
    STAB annual revenue is $1.49 million

    Revenue Analysts estimate

    -
    STAB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +100%
    STAB annual revenue is up +100% year-on-year

    Revenue Sector rank

    38.19%
    STAB annual revenue is higher than 38.19% of companies in Healthcare sector

    EPS

    EPS

    -$2.90
    STAB annual earnings per share is -$2.90

    EPS Analysts estimate

    -
    STAB annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -74.7%
    STAB annual earnings per share is down -74.7% year-on-year

    EPS Sector rank

    29.81%
    STAB annual earnings per share is higher than 29.81% of companies in Healthcare sector

    Profit

    Gross profit

    $743.10K
    STAB annual gross profit is $743.10 thousand

    Gross margin

    49.97%
    STAB annual gross profit margin is 49.97%

    Operating profit

    -$29.94M
    STAB annual operating income is -$29.94 million

    Operating margin

    -2013.64%
    STAB annual operating profit margin is -2013.64%

    Net income

    -$101.88M
    STAB annual net profit is -$101.88 million

    Net margin

    -6851.06%
    STAB annual net profit margin is -6851.06%

    Expenses

    Total expenses

    $103.34M
    STAB annual total expenses is $103.34 million

    Operating expenses

    $30.69M
    STAB annual total operating expenses is $30.69 million

    Cost of goods sold

    $743.90K
    STAB annual cost of goods sold is $743.90 thousand

    Selling, general & administrative expenses

    $19.91M
    STAB annual SGA is $19.91 million

    Depreciation and amortization

    $255.60K
    STAB annual depreciation & amortization is $255.60 thousand

    Interest expense

    $0.00
    STAB annual interest expense is $0.00

    Income tax

    $0.00
    STAB annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$29.94M
    STAB annual earnings before interest & taxes is -$29.94 million

    EBITDA

    -$29.69M
    STAB annual EBITDA is -$29.69 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $21.17M
    STAB annual total assets is $21.17 million

    Non current assets

    $17.01M
    STAB annual long term assets is $17.01 million

    Current assets

    $3.54M
    STAB annual total current assets is $3.54 million

    Cash and cash equivalents

    $1.98M
    STAB annual cash & cash equivalents is $1.98 million

    Accounts receivable

    $216.20K
    STAB annual accounts receivable is $216.20 thousand

    Inventory

    $0.00
    STAB annual inventory is $0.00

    Liabilities

    Total liabilities

    $22.68M
    STAB annual total liabilities is $22.68 million

    Long term liabilities

    $11.43M
    STAB annual total long term liabilities is $11.43 million

    Current liabilities

    $11.25M
    STAB annual total current liabilities is $11.25 million

    Accounts payable

    $3.96M
    STAB annual accounts payable is $3.96 million

    Debt

    Total debt

    $16.26M
    STAB annual total debt is $16.26 million

    Total debt 1-year change

    +711.68%
    STAB annual total debt is up +711.68% year-on-year

    Long term debt

    $11.43M
    STAB annual long term debt is $11.43 million

    Short term debt

    $4.83M
    STAB annual short term debt is $4.83 million

    Equity & Capital

    Shareholders equity

    -$1.57M
    STAB annual stockholders equity is -$1.57 million

    Book value

    -$1.57M
    STAB annual book value is -$1.57 million

    Retained earnings

    -$129.48M
    STAB annual retained earnings is -$129.48 million

    Working capital

    -$7.71M
    STAB annual working capital is -$7.71 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$28.06M
    STAB annual cash flow from operations is -$28.06 million

    Cash from operations 1-year change

    -452.11%
    STAB annual cash flow from operations is down -452.11% year-on-year

    Cash from investing

    $13.46M
    STAB annual cash flow from investing activities is $13.46 million

    Cash from investing 1-year change

    +140339.58%
    STAB annual cash flow from investing activities is up +140339.58% year-on-year

    Cash from financing

    $20.99M
    STAB annual cash flow from financing activities is $20.99 million

    Cash from financing 1-year change

    +269.24%
    STAB annual cash flow from financing activities is up +269.24% year-on-year

    CAPEX

    CAPEX

    $183.00K
    STAB annual capital expenditures is $183.00 thousand

    CAPEX 1-year change

    +1806.25%
    STAB annual capital expenditures is up +1806.25% year-on-year

    Free Cash Flow

    Free cash flow

    -$28.24M
    STAB annual free cash flow is -$28.24 million

    Free cash flow 1-year change

    -454.66%
    STAB annual free cash flow is down -454.66% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    49.97%
    STAB annual gross profit margin is 49.97%

    Operating margin

    -2013.64%
    STAB annual operating profit margin is -2013.64%

    Net margin

    -6851.06%
    STAB annual net profit margin is -6851.06%

    ROA & ROE

    ROA

    -917.58%
    STAB annual return on assets is -917.58%

    ROE

    6497.14%
    STAB annual return on equity is 6497.14%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    STAB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    STAB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.00
    STAB price to book ratio is 0.00

    PB ratio Sector rank

    17.83%
    STAB price to book ratio is higher than 17.83% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.00
    STAB price to sales ratio is 0.00

    PS ratio Sector rank

    2.1%
    STAB price to sales ratio is higher than 2.1% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $6.91M
    STAB enterprise value is $6.91 million

    Enterprise value Sector rank

    19.97%
    STAB enterprise value is higher than 19.97% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.34
    STAB EV/EBITDA is -0.34

    EV/EBITDA Sector rank

    57.22%
    STAB EV/EBITDA is higher than 57.22% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.31
    STAB annual current ratio is 0.31

    Quick ratio

    0.31
    STAB annual quick ratio is 0.31

    Leverage

    Debt to equity

    -10.37
    STAB annual debt to equity ratio is -10.37

    Interest coverage ratio

    -
    STAB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    STAB piotroski f-score is 4

    Altman Z-Score

    -13.60
    STAB altman z-score is -13.60

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with STAB included

    Stocks cheaper than 1 dollar
    US stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    Small cap stocks
    Stocks with low beta
    • What is the ticker symbol for Statera Biopharma, Inc.?
    • Does Statera Biopharma, Inc. pay dividends?
    • What sector is Statera Biopharma, Inc. in?
    • What industry is Statera Biopharma, Inc. in?
    • What country is Statera Biopharma, Inc. based in?
    • When did Statera Biopharma, Inc. go public?
    • Is Statera Biopharma, Inc. in the S&P 500?
    • Is Statera Biopharma, Inc. in the NASDAQ 100?
    • Is Statera Biopharma, Inc. in the Dow Jones?
    • When was Statera Biopharma, Inc.'s last earnings report?
    • When does Statera Biopharma, Inc. report earnings?

    What is the ticker symbol for Statera Biopharma, Inc.?

    The ticker symbol for Statera Biopharma, Inc. is NASDAQ:STAB

    Does Statera Biopharma, Inc. pay dividends?

    No, Statera Biopharma, Inc. does not pay dividends

    What sector is Statera Biopharma, Inc. in?

    Statera Biopharma, Inc. is in the Healthcare sector

    What industry is Statera Biopharma, Inc. in?

    Statera Biopharma, Inc. is in the Biotechnology industry

    What country is Statera Biopharma, Inc. based in?

    Statera Biopharma, Inc. is headquartered in United States

    When did Statera Biopharma, Inc. go public?

    Statera Biopharma, Inc.'s initial public offering (IPO) was on July 28, 2021

    Is Statera Biopharma, Inc. in the S&P 500?

    No, Statera Biopharma, Inc. is not included in the S&P 500 index

    Is Statera Biopharma, Inc. in the NASDAQ 100?

    No, Statera Biopharma, Inc. is not included in the NASDAQ 100 index

    Is Statera Biopharma, Inc. in the Dow Jones?

    No, Statera Biopharma, Inc. is not included in the Dow Jones index

    When was Statera Biopharma, Inc.'s last earnings report?

    Statera Biopharma, Inc.'s most recent earnings report was on May 17, 2022

    When does Statera Biopharma, Inc. report earnings?

    The date for Statera Biopharma, Inc.'s next earnings report has not been announced yet
    On this page